3-quinuclidinyl-4-iodobenzilate has been researched along with Sensitivity and Specificity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, D; Chisholm, JA; Owens, J; Patterson, J; Pimlott, S; Wyper, D | 1 |
| Ell, PJ; Erlandsson, K; Murphy, DG; Norbury, R; Owens, J; Travis, MJ; Waddington, W | 1 |
2 trial(s) available for 3-quinuclidinyl-4-iodobenzilate and Sensitivity and Specificity
| Article | Year |
|---|---|
Acetylcholine muscarinic receptors and response to anti-cholinesterase therapy in patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Quinuclidinyl Benzilate; Radionuclide Imaging; Radiopharmaceuticals; Receptor, Muscarinic M1; Receptors, Muscarinic; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Technetium Tc 99m Exametazime; Tissue Distribution; Treatment Outcome | 2003 |
SPET imaging of central muscarinic receptors with (R,R)[123I]-I-QNB: methodological considerations.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Brain; Female; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Quinuclidinyl Benzilate; Radiopharmaceuticals; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2004 |